Safety and Efficacy of VDPHL01 in Males With AGA

Clinical trial NCT06972264 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06972264
Sponsor: Veradermics, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Androgenetic Alopecia AGA Male Pattern Baldness

Start date: 2025-03-11
Primary completion: 2026-12-01
Enrollment: 480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.